ERBB2 and adenocarcinoma: Lung biopsy confirmed TTF-1 and Napsin A-positive adenocarcinoma, and genomic profiling identified an ERBB2 (HER2) exon 20 insertion mutation (p.A775_G776insYVMA; VAF 3.9%).